Invesco’s Zura Bio ZURA Stock Holding History

Invesco’s Portfolio ZURA Stock Details ZURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-21,456	Closed	-$55.1K	–	3984
2024 Q1	$55.1K	Sell	21,456 -98,984	-82%	-$351K	﹤0.01%	3794
2023 Q4	$562K	Buy	120,440 +2,282	+2%	+$11.4K	﹤0.01%	3154
2023 Q3	$780K	Buy	118,158 +59,049	+100%	+$395K	﹤0.01%	2983
2023 Q2	$485K	Buy	+59,109	New	+$475K	﹤0.01%	3260

Other funds holding ZURA

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco's ZURA Position: Q2 2024 in Review

Invesco sold out of Zura Bio (ZURA) in Q2 2024, closing a stake of 21,456 shares — an estimated $55.1K sold.

Invesco first reported a position in ZURA in Q2 2023 and held it in 4 quarters. The position peaked at $780K in Q3 2023. 57 funds tracked by Wall St. Rank hold ZURA as of Q2 2024.

Invesco reported no remaining Zura Bio position as of Q2 2024 after selling out during the quarter.
Invesco sold 21,456 Zura Bio shares in Q2 2024, an estimated $55.1K.
Invesco first reported a position in Zura Bio in Q2 2023 and held it in 4 quarters.
Invesco's Zura Bio position peaked at $780K in Q3 2023.
57 funds tracked by Wall St. Rank held Zura Bio as of Q2 2024.

Based on Invesco's 13F filing for Q2 2024, filed 13 Aug 2024.